Cellectis (CLLS) Tops Q1 EPS by 8c

Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.18), $0.08 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.02 million versus the consensus estimate of $13.02 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"
• Stria Lithium rebrands as Arc Mineral Royalties after gold deal